The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusStandards of medical care in diabetes--2012Cardiovascular Outcome Studies in Diabetes: How Do We Make Sense of These New Data?Sodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metforminHypoglycemia in Patients with Diabetes and Renal DiseaseLow HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalInsulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesCardiovascular importance of hyperglycemia and hypoglycemiaCausative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetesGlycemic control and cardiovascular disease: what's a doctor to do?Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusUpdate on the treatment of type 2 diabetes mellitusEffect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trialsAddition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisCardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesStandards of medical care in diabetes--2013Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.Diabetes mellitus--a global pandemic. Keynote lecture presented at the Wonca conference in Prague in June 2013.Clinical therapeutic strategies for early stage of diabetic kidney disease.The glucose triad and its role in comprehensive glycaemic control: current status, future management.Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study.What can we learn from the recent blood glucose lowering megatrials?Optimal therapy of type 2 diabetes: a controversial challengeThe effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence.Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitusIntensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trialsEffects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart diseaseLong-term effects of intensive glucose lowering on cardiovascular outcomes.Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients.
P2860
Q22241288-4B3A7D24-D07F-4A13-A144-32D289C83E67Q22241786-89C9E608-BF41-48D7-8C68-04EEE559CE39Q24186667-F6D26973-E03F-48EB-9088-0AA8E4422142Q24202505-FAFC0D58-EA3A-4BB4-8A05-5E0BE548FE41Q24236456-92C4365B-C7FA-4FE1-A5E2-CD9AFCE0D515Q24632533-19D3E44C-58AA-4D00-8D57-F0DC53FCD53CQ26752255-904A9593-A2B4-48F7-BD15-3E5CA23E6817Q26752815-A9F98B4E-CBB4-4BC5-BE54-5C92F7D04D92Q26799515-D1CAF0AB-BCAF-45F8-A39A-9A1D4727C357Q26799903-A4EA1B27-7BE5-4CC4-B118-0A46B9621DE1Q26827620-5D34F08D-77C8-402E-ABA0-3DA7EAE8C1D5Q26866924-94D49708-BEB1-4BA6-A2D5-2CE86D8E0680Q26999390-960CEE1B-0BB4-41F7-9094-D9CA0795FB1DQ27008460-4926D3C0-B905-4B77-9B55-60434980B5AFQ27024469-370AA169-097F-4CC4-811F-7B3CC4DC5A17Q27687851-11804EF7-06C8-4C45-93E3-2CDD38A47083Q28072980-8C9F5531-110C-473F-8E68-C33FBA500517Q28073342-B56CAAAF-0E75-48B2-BFA1-937355B1B016Q28256514-5D8AF371-10A8-4B4B-A3F8-BE3FF09CB598Q28275281-D2FF08CE-2A33-4DE8-AD01-10A7ABD39B4FQ28741419-CD4EC334-A2EB-4A30-8FE9-AD5AA430D88EQ29620309-32275FEB-682C-45F2-90E4-2237D99269BCQ30276113-93BBECDE-5C60-4CF6-AE8E-449D48D15CA4Q30357022-408D6BE0-C7A8-46AA-BE7B-2529EA0AAE95Q30363683-B3133378-6D3A-4E56-A410-25C249E032A2Q30393989-12716B6F-16F2-4B28-9DBD-DBCACE508B7AQ30491380-B073371A-A194-4D8B-B5DC-8A58AC9ACED7Q30840447-C5A15FC9-3A3E-4A04-B7E8-F657E1C776A9Q30891945-C5BBA0A2-DA82-4223-8BEC-848316FEC816Q33164073-ADD49792-B88D-4B48-9EF5-D737B95E3C16Q33558383-EE7D4771-9159-4010-988A-47A2C80EE0E3Q33577712-F3C015B3-A381-43D6-AB1F-F1C6798E2879Q33579759-DBF1C9AF-F95F-403B-BB01-339848166B9BQ33610427-FF079D99-627C-4A81-A89C-AB2F42AD681AQ33699361-2D2027B1-46EC-4CB8-B585-2CBB332DA936Q33753663-5DE29F0C-1251-4DFB-9ED5-DAFDDFEC1262Q33801801-D124B33C-783D-4AFF-9054-D4CF2FB77313Q33834187-0662096C-E9CC-4D38-A927-6294A05167DEQ33851861-F6A8E9C1-297C-4656-B772-C29108205743Q33857845-A4889E89-3BDA-44F8-8BA3-E2494DF9F0EE
P2860
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The association between sympto ...... l analysis of the ACCORD study
@ast
The association between sympto ...... l analysis of the ACCORD study
@en
The association between sympto ...... analysis of the ACCORD study.
@nl
type
label
The association between sympto ...... l analysis of the ACCORD study
@ast
The association between sympto ...... l analysis of the ACCORD study
@en
The association between sympto ...... analysis of the ACCORD study.
@nl
prefLabel
The association between sympto ...... l analysis of the ACCORD study
@ast
The association between sympto ...... l analysis of the ACCORD study
@en
The association between sympto ...... analysis of the ACCORD study.
@nl
P2093
P2860
P921
P356
P1433
P1476
The association between sympto ...... l analysis of the ACCORD study
@en
P2093
Angela R Kimel
Byron Hoogwerf
Debra L Simmons
Denise E Bonds
Elizabeth R Seaquist
Faramarz Ismail-Beigi
Jeff A Cutler
Joann M Speril-Hillen
Karen R Horowitz
Mary Ellen Sweeney
P2860
P356
10.1136/BMJ.B4909
P407
P577
2010-01-08T00:00:00Z